You are currently viewing a new version of our website. To view the old version click .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 23, Issue 1

February 2016 - 23 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (23)

  • Article
  • Open Access
16 Citations
1,005 Views
8 Pages

1 February 2016

Objective: We explored the role of insulin-like growth factor 1 (igf-1) in the development of lung cancer. We used immunohistochemistry to measure the expression of igf-1 and igf-1 receptor (igf-1r) in specimens of tissue and perioperative circulatio...

  • Article
  • Open Access
8 Citations
922 Views
6 Pages

Quebec Public Funding Facilitates Fertility Preservation for Male Cancer Patients

  • M.B. Herrero,
  • A. García,
  • W. Buckett,
  • T. Tulandi and
  • P. Chan

1 February 2016

Background: Sperm cryopreservation remains the only clinically feasible option to preserve male fertility. The quality of counselling provided by the treating physicians and the cost of sperm cryopreservation can both influence a patient’s decision a...

  • Article
  • Open Access
49 Citations
1,497 Views
8 Pages

1 February 2016

Objectives: Adenoid cystic carcinoma (ACC) is often treated with surgery, with or without adjuvant radiation therapy (RT). We evaluated disease characteristics, treatments, and potentially prognostic variables in patients with ACC. Methods: Our retr...

  • Review
  • Open Access
22 Citations
1,006 Views
8 Pages

1 February 2016

T-Cell acute lymphoblastic leukemia (T-ALL) is a malignancy of white blood cells, characterized by an uncontrolled accumulation of T-cell progenitors. During leukemic progression, immature T cells grow abnormally and crowd into the bone marrow, preve...

  • Article
  • Open Access
28 Citations
1,345 Views
10 Pages

A Canadian Perspective on the Use of Immunoglobulin Therapy to Reduce Infectious Complications in Chronic Lymphocytic Leukemia

  • S. Lachance,
  • A.L. Christofides,
  • J.K. Lee,
  • L.H. Sehn,
  • B.C. Ritchie,
  • C. Shustik,
  • D.A. Stewart,
  • C.L. Toze,
  • E. Haddad and
  • D.C. Vinh

1 February 2016

Infections are a major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), who typically have increased susceptibility because of hypogammaglobulinemia (HGG) related to their disease and its treatment. Immunoglobulin...

  • Article
  • Open Access
2 Citations
840 Views
4 Pages

Eastern Canadian Colorectal Cancer Consensus Conference 2013: Emerging Therapies in the Treatment of Pancreatic, Rectal, and Colorectal Cancers

  • T. Di Valentin,
  • T. Asmis,
  • J. Asselah,
  • F. Aubin,
  • N. Aucoin,
  • S. Berry,
  • J. Biagi,
  • C.M. Booth,
  • R. Burkes and
  • N. Coburn
  • + 24 authors

1 February 2016

The annual Eastern Canadian Colorectal Cancer Consensus Conference held in Montreal, Quebec, 17–19 October 2013, marked the 10-year anniversary of this meeting that is attended by leaders in medical, radiation, and surgical oncology. The goal of the...

  • Short Communication
  • Open Access
7 Citations
687 Views
4 Pages

1 February 2016

Background: Many prostate cancers (pcas) are indolent and, if left untreated, are unlikely to cause death or morbidity in a man’s lifetime. As a result of testing for prostate-specific antigen, more such cases are being identified, leading to concern...

  • Article
  • Open Access
7 Citations
896 Views
7 Pages

1 February 2016

Objective: We explored the relationship between HLA-DRB1 allele polymorphisms and familial aggregation of hepatocellular carcinoma (fHCC). Methods: Polymerase chain reaction sequence-specific primers were used to determine HLA-DRB1 genotypes for 130...

of 3